News & Insights

Q&A with New Partner, Cissy Young, about Her Non-Linear Career Path

Cissy Young, who joined Catalyst Advisors at the beginning of 2023 as a Partner, has had afascinating career journey. Her rich set of experiences in the biopharma industry—from herscientific training to working on early-stage company formation and financing, to businessdevelopment and strategy— has enabled her to quickly assess business contexts and understand diverse perspectives

Catalyst Advisors LP Appoints New Partner to Support Global Expansion, Commitment to DE&I-Focused Leadership

NEW YORK–(BUSINESS WIRE)–Catalyst Advisors LP, an international executive recruitment and assessment firm singularly focused on life sciences, today announced that Cissy Young, PhD, will join the firm as a partner. Based in Boston, Dr. Young is a trusted advisor to Boards and CEOs on leadership topics, including assessment, recruitment and development of executive talent,

Catalyst Advisors LP Appoints New Director to Support European Expansion

NEW YORK, July 26, 2022 – Catalyst Advisors LP, an international executive recruitment and assessment firm singularly focused on life sciences, announced today the appointment of new Director, Andrew (AJ) MacBride Brown. Mr. MacBride Brown’s robust search and advisory experience in the life sciences industry will be instrumental in connecting high-caliber board and C-suite

Our Takeaways: Highlights from Recent BioPharma R&D Conferences

Members of the Catalyst Advisors team attended multiple private, VC-sponsored conferences recently. It was a joy to get back to live, in-person meetings. The presentations sparked some timely ideas, and the hallway encounters led to engaging and open conversations with many research and development and regulatory leaders in our industry. The conference presentations and

Why I Chose to Join Catalyst Advisors

After more than 20 years at a large global recruiting firm, I left. I wanted to focus on clients with innovative therapeutics and work in a more collaborative corporate culture. At the big firm, there were 200-plus engagements per year in health care, but a large proportion of those was with hospital groups, diagnostics,